philips respironics performax pediatric se total face mask
philips electronics singapore pte ltd - general hospital - the performax pediatric se total face mask is intended to provide a patient interface for application of noninvasive ventilation. the mask is to be used as an accessory to ventilators which have adequate alarms and safety systems for ventilator failure, and which are intended to administer cpap or positive pressure ventilation for treatment of respiratory failure, respiratory insufficiency, or obstructive sleep apnea. the mask is for multiple use /single use in the hospital/institutional environment only. the mask is to be used on patients 1 year or older (>7 kg) who are appropriate candidates for noninvasive ventilation.
resmed pixi pediatric mask
resmed asia pte. ltd. - anaesthesiology - the pixi pediatric mask channels airflow noninvasively to a patient from a continuous positive airway pressure (cpap) or bilevel device (‘device’). it is: • to be used by children aged between 2 and 7 for whom continuous positive airway pressure (cpap) or bilevel therapy has been prescribed • intended for single-patient re-use in the home and single patient re-use in the hospital/institutional environment.
algidrin pediatric 20mg/ml oral suspension
laboratorio de aplicaciones farmacodinamicas s.a. grassot, 16, 08025, barcelona, spain - ibuprofen - oral suspension - ibuprofen 20 mg - antiinflammatory and antirheumatic products
tempracof 7.5mg/ ml pediatric drops
taisho pharmaceuticals (philippines), inc. - ambroxol hydrochloride - pediatric drops - 7.5mg/ ml
ambrosyn 15 mg / 5 ml pediatric syrup
ambroxol hydrochloride - pediatric syrup - 15 mg / 5 ml
sybroxol 15mg/ml pediatric syrup
sydenham laboratories, inc. - ambroxol hydrochloride - pediatric syrup - 15mg/ml
quantimetrix bilirubin control – pediatric
all eights (singapore) private limited - clinical chemistry - the quantimetrix pediatric bilirubin control is intended as a means of monitoring various bilirubin assay methods to validate quantitation of patient samples. control materials having known component concentrations are an integral part of diagnostic procedures. daily monitoring of control values establishes intralaboratory parameters for accuracy and precision of the test method.
florafol pediatric 0.25 mg/ml multivitamin and fluoride liquid drops (vitamin a (as retinyl palmitate) vitamin c (as ascorbic ac
pangea pharmaceuticals, llc - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridox - florafol™ pediatric 0.25 mg/ml fluoride, is a multivitamin and fluoride prescription product providing essential vitamins, minerals and fluoride. do not use in areas where drinking water exceeds 0.6 ppm fluoride. do not administer to pediatric patients less than 6 months old.
florafol fe pediatric 0.25 mg/ml multivitamin and fluoride liquid drops (vitamin a (as retinyl palmitate) vitamin c (as ascorbic
pangea pharmaceuticals, llc - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridox - florafol™ fe pediatric 0.25 mg/ml fluoride (with iron), is a multivitamin and fluoride prescription product providing essential vitamins, minerals and fluoride. do not use in areas where drinking water exceeds 0.6 ppm fluoride. do not administer to pediatric patients less than 6 months old.
pediacel suspension for injection. diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and haemop
sanofi pasteur s.a. - pertactin 3 µg, pertussis toxoid 20 µg, poliovirus (inactivated) type 1 (mahoney strain) 40 dagu, poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu, poliovirus (inactivated) type 3 (saukett strain) 32 dagu, diphtheria toxoid, filamentous haemagglutinin (fha) 20 µg, fimbriae types 2 and 3 5 µg, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg, tetanus toxoid - suspension for injection